| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 02/17/2004 | US6693108 Pyrimidinyl-guanidine derivatives |
| 02/17/2004 | US6693103 1,2,3,4-tetrahydro-2-thioxo-quinolinyl and 1,2,3,4-tetrahydro-2-oxo-quinolinyl derivatives as progesterone receptor modulators |
| 02/17/2004 | US6692975 Compounds for use in the detection of preferential particles in sample |
| 02/17/2004 | CA2302965C Processes and intermediates for preparing anti-cancer compounds |
| 02/17/2004 | CA2280279C Indole, indazole and benzimidazole derivatives as antithrombotic agents |
| 02/17/2004 | CA2124680C Piperazine derivatives as 5-ht1a antagonists |
| 02/12/2004 | WO2004013234A2 Metal complexes as light-absorbing compounds in the information layer of optical data carriers |
| 02/12/2004 | WO2004013131A2 Pyridines and pyrimidines substituted by 4-trifluoromethylpyrazolyl |
| 02/12/2004 | WO2004013130A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 02/12/2004 | WO2004013102A1 Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines |
| 02/12/2004 | WO2004013101A2 N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy |
| 02/12/2004 | WO2004012735A2 New effector conjugates, process for their production and their pharmaceutical use |
| 02/12/2004 | WO2004012656A2 Thiophene and furan derivatives as prostaglandin agonists and use thereof |
| 02/12/2004 | WO2003096979A3 Drug therapy for celiac sprue |
| 02/12/2004 | WO2003070236A3 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 02/12/2004 | WO2003049702A3 Vanilloid receptor ligands and their use in treatments |
| 02/12/2004 | WO2003037916A3 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 02/12/2004 | WO2003010159A8 Piperidine derivatives as nmda receptor antagonists |
| 02/12/2004 | WO2002083863A3 Thiazole and other heterocyclic ligands and use thereof |
| 02/12/2004 | WO2002058698A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 02/12/2004 | US20040030137 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 02/12/2004 | US20040030132 Anticancer agents; arterosclerosis; bone disorders; antiarthritic agents; vision defects |
| 02/12/2004 | US20040029940 Methods of treating factor VIIa-associated conditions with compounds having an amine nucleus |
| 02/12/2004 | US20040029939 Inhibitors of IMPDH enzyme |
| 02/12/2004 | US20040029935 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 02/12/2004 | US20040029933 Substituted phenylacetic acids |
| 02/12/2004 | US20040029925 Central nervous system disorders; psychological disorders; gastrointestinal disorders |
| 02/12/2004 | US20040029920 2-(biarylalkyl)amino-3-(heterocyclylcarbonylamino)-pyridine derivatives |
| 02/12/2004 | US20040029919 Respiratory system disorders; bronchitis; irritable bowel disorders; incontinence |
| 02/12/2004 | US20040029902 2,4-Pyrimidinediamine compounds and their uses |
| 02/12/2004 | US20040029898 Anticancer agents |
| 02/12/2004 | US20040029887 Cardiovascular disorders; antiinflammatory agents; central nervous system diosrders; psychological disorders |
| 02/12/2004 | US20040029886 Dihalopropene compounds, processes for their preparation, compositions comprising them and their use as pesticides |
| 02/12/2004 | US20040029875 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same |
| 02/12/2004 | US20040029867 Anticoagulants; cardiovascular disorders |
| 02/12/2004 | US20040029862 Alzheimer's disease |
| 02/12/2004 | US20040029861 Using compound containing pyridine ring |
| 02/12/2004 | US20040029858 Antitumor agents; solid tumors of rectum, lungs |
| 02/12/2004 | US20040029837 Red fluorescence dyes; labels |
| 02/12/2004 | US20040029734 Fused-benzene derivatives useful as herbicides |
| 02/12/2004 | DE10234975A1 New effector conjugates of epithilones useful to treat e.g. diseases associated with proliferative processes, neurodegenerative diseases, multiple sclerosis, Alzheimer's disease and rheumatoid arthritis |
| 02/12/2004 | CA2494593A1 4-trifluormethylpyrazolyl-substituted pyridines and pyrimidines |
| 02/12/2004 | CA2494114A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 02/12/2004 | CA2492437A1 New effector conjugates, process for their production and their pharmaceutical use |
| 02/11/2004 | EP1388341A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 02/11/2004 | EP1387842A1 Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors |
| 02/11/2004 | EP1387830A1 Novel 4-anilinoquinoline-3-carboxamides |
| 02/11/2004 | EP1387679A1 Sulfonamides |
| 02/11/2004 | EP1299356B1 Novel compounds |
| 02/11/2004 | EP1224177B1 Process for preparing oxazolines from tetrahydrofurans |
| 02/11/2004 | EP1216239B1 Piperazine derivatives as 5-ht1b antagonists |
| 02/11/2004 | EP1157998B1 Heterocyclic compounds, intermediates thereof and elastase inhibitors |
| 02/11/2004 | EP1144393B1 Benzoxazole derivatives for use as integrin inhibitors |
| 02/11/2004 | EP1020462B1 Heterocyclic compounds and antitumor agent containing the same as active ingredient |
| 02/11/2004 | EP0901479B1 Isoxazole derivatives and their use as herbicides |
| 02/11/2004 | CN1474812A (Dihydro) isoquinoline derivatives as phosphodiesterase inhibitor |
| 02/11/2004 | CN1474805A 2-amino-2-alkyl-5-heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/11/2004 | CN1474804A 2-amino-2-alkyl-4-hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/11/2004 | CN1473827A 3-position substituted quinolone derivativers and its use in pharmacy |
| 02/11/2004 | CN1137888C Inhibitor of cysteninyl aspartic acid proteinase |
| 02/11/2004 | CN1137886C Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives |
| 02/11/2004 | CN1137884C Indazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use |
| 02/10/2004 | US6689888 Processes and intermediates useful in preparing β3-adrenergic receptor agonists |
| 02/10/2004 | US6689886 Treatment of inflammation and other immune disorders |
| 02/10/2004 | US6689800 β3-adrenergic receptor agonist crystal forms, processes for the production thereof, and uses thereof |
| 02/10/2004 | US6689794 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 02/10/2004 | US6689787 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia |
| 02/10/2004 | US6689782 3-piperazinyl-2-diarylurea-quinazolinone derivatives; potentiators of antifungal agents |
| 02/10/2004 | US6689779 Pyridine or pyrimidine substituted; antibacterial activity; low toxicity |
| 02/10/2004 | US6689778 2-phenylamino-5-isoxazo-4-yl-pyrimidine derivatives |
| 02/10/2004 | US6689770 Aryl sulfonyls as factor Xa inhibitors |
| 02/10/2004 | US6689769 Bactericides |
| 02/10/2004 | US6689765 Viricides; antiinflammatory agents |
| 02/10/2004 | CA2223551C Benzimidazole compounds |
| 02/10/2004 | CA2108903C Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 02/05/2004 | WO2004011460A2 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents |
| 02/05/2004 | WO2004011457A1 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof |
| 02/05/2004 | WO2004011448A1 Therapeutic compounds for treating dyslipidemic conditions |
| 02/05/2004 | WO2004011447A2 Method for preparing fused oxazinones from ortho-amino aromatic carboxylic acid and a carboxylic acid in the presence of a sulfonyl chloride and pyridine |
| 02/05/2004 | WO2004011446A1 Indane, dihydrobenzofuran, and tetrahydronaphthalene carboxylic acid derivatives and their use as antidiabetics |
| 02/05/2004 | WO2004011443A1 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 02/05/2004 | WO2004011436A1 Quinoline derivatives and their use as mycobacterial inhibitors |
| 02/05/2004 | WO2004011427A2 Substituted benzanilides as modulators of the ccr5 receptor |
| 02/05/2004 | WO2004011425A2 Indole, azaindole and related heterocyclic ureido and thioureido piperazine derivatives |
| 02/05/2004 | WO2004011418A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands |
| 02/05/2004 | WO2004010995A1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthristis |
| 02/05/2004 | WO2004010945A2 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use |
| 02/05/2004 | WO2004010943A2 Substituted benzanilides as modulators of the ccr5 receptor |
| 02/05/2004 | WO2004010936A2 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders |
| 02/05/2004 | WO2004010761A2 Pesticidal cyanine dye derivatives |
| 02/05/2004 | WO2002100886A8 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 02/05/2004 | US20040024399 Method for repairing damaged intervertebral discs |
| 02/05/2004 | US20040024222 Such as 5-(4-(2-(5-Methyl-2-phenyl-oxazol-4-yl)-ethoxy)-benzo(b)thiophen-7 -ylmethyl)2,4-thiazolidinedione via bromo-/chloro-methylation; for treatment of diabetes |
| 02/05/2004 | US20040024207 8'4-'3-(5Fluoro-1h-indol-3yl)propyl!-1-piperazinyl!-2-methyl-2h-1,4-benzoxazin-3(4h)-one methanesulfonate with high affinity for the dopamine d2 receptor and the seotonix reuptake site |
| 02/05/2004 | US20040024190 Viral polymerase inhibitors |
| 02/05/2004 | US20040024066 E.g., N-(2-(Benzo(b)thiophen-5-ylmethanesulfonyl)-1-(3,4-dichloro- phenyl)- ethyl)-N-hydroxyformamide; gene expression inhibitors of s-CD23; autoimmune disease; antiallergens; matrix metalloprotease enzyme inhibitors |
| 02/05/2004 | US20040024059 Novel pleuromutilin derivatives |
| 02/05/2004 | US20040024035 Oxazole derivatives useful as growth factor receptor tyrosine kinase (particularly HER2) inhibitors; for preventing or treating cancer |
| 02/05/2004 | US20040024034 For modulating a peroxisome proliferator activated receptor, particularly in the treatment of diabetes mellitus |
| 02/05/2004 | US20040024030 Such as 4-chloro-5-(2-phenyl-thiazol-5-yl)-2H-pyrazole-3-carboxylic acid ethyl amide; for inhibiting topoisomerases; treating bacterial infections in mammals |